Consolidated Investment Group’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,200
| Closed | -$1.88M | – | 73 |
|
|
2020
Q3 | $1.88M | Hold |
18,200
| – | – | 0.63% | 47 |
|
|
2020
Q2 | $1.44M | Sell |
18,200
-18,800
| -51% | -$1.49M | 0.54% | 46 |
|
|
2020
Q1 | $2.14M | Hold |
37,000
| – | – | 0.95% | 31 |
|
|
2019
Q4 | $2M | Hold |
37,000
| – | – | 0.94% | 32 |
|
|
2019
Q3 | $1.93M | Sell |
37,000
-28,000
| -43% | -$1.46M | 1% | 33 |
|
|
2019
Q2 | $3.14M | Hold |
65,000
| – | – | 1.64% | 25 |
|
|
2019
Q1 | $3.28M | Hold |
65,000
| – | – | 1.64% | 23 |
|
|
2018
Q4 | $3.85M | Hold |
65,000
| – | – | 1.97% | 19 |
|
|
2018
Q3 | $4.28M | Hold |
65,000
| – | – | 2% | 19 |
|
|
2018
Q2 | $3.28M | Hold |
65,000
| – | – | 1.59% | 27 |
|
|
2018
Q1 | $3.42M | Buy |
+65,000
| New | +$3.42M | 1.66% | 24 |
|